HIA
RVMD icon

HFM Investment Advisors’s Revolution Medicines RVMD Stock Holding History

HFM Investment Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562 Sell
3
-3
-50% -$438 ﹤0.01% 953
2026
Q1 		$584 Hold
6
– – ﹤0.01% 610
2025
Q4 		$478 Buy
6
+3
+100% +$197 ﹤0.01% 730
2025
Q3 		$140 Sell
3
-1
-25% -$39 ﹤0.01% 1091
2025
Q2 		$147 Buy
+4
New +$154 ﹤0.01% 1072

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

HFM Investment Advisors's RVMD Position: Q2 2026 in Review

HFM Investment Advisors reduced its Revolution Medicines (RVMD) stake by 50% in Q2 2026, selling an estimated $438 and leaving 3 shares worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #953.

HFM Investment Advisors first reported a position in RVMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $584 in Q1 2026. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • HFM Investment Advisors held 3 shares of Revolution Medicines worth $562 as of Q2 2026.
  • HFM Investment Advisors sold 3 Revolution Medicines shares in Q2 2026, an estimated $438.
  • Revolution Medicines made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #953 holding.
  • HFM Investment Advisors first reported a position in Revolution Medicines in Q2 2025 and has held it in 5 quarters since.
  • HFM Investment Advisors's Revolution Medicines position peaked at $584 in Q1 2026.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.